Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
CRYO AMERICAN CRYOSTEM CORPORATION
0.107-0.002-1.83%
Close
02/07 16:00 ET
High
0.110
Open
0.110
Turnover
278.26
Low
0.107
Pre Close
0.109
Volume
2.54K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
American CryoStem Announces Patient Treatment Status for its Phase I Clinical Trial for Post-Concussion Syndrome (PCS)
EATONTOWN, NJ / ACCESSWIRE / March 4, 2022 / American CryoStem Corporation (OTC PINK:CRYO) a clinical stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and
American CryoStem Announces Completion of Patient Recruitment for its Post-Concussion Syndrome (PCS) ATCELL(TM) Phase I Clinical Trial
EATONTOWN, NJ / ACCESSWIRE / December 22, 2021 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing
American CryoStem Completes Clinical Protocol Design for Long COVID Study
EATONTOWN, NJ / ACCESSWIRE / November 30, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a leading clinical-stage biotechnology developer of adipose-derived stem cell therapies today announced
American CryoStem to Study New Standardized Treatment Protocols for Wound Healing
EATONTOWN, NJ / ACCESSWIRE / November 16, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing
No More
Company Overview
More
American CryoStem Corp. is engaged in the development, market, and licenses patented adipose tissue-based cellular technologies, bio-materials, and related proprietary services. It focuses on clinical processing, commercial bio-banking, and application development for adipose tissue and adipose-derived stem cells, and also provides contract manufacturing services to physicians and other medical professionals that perform tissue transfer and other cellular therapy services, as well as offers professional services, including sterility, viability, cellular density, and growth assay analysis. The company was founded by Anthony Francis Dudzinski in 2008 and is headquartered in Eatontown, NJ.
CEO： --
Market： Pink Market
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet